Listed

Cresco Labs Inc.: Form 40-F for the period ended Dec 31, 2021

Filed with the SEC on Apr 5, 2022 and accepted by EDGAR at Apr 5, 2022, 17:19 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2021-01-01 to 2021-12-31$821.7mifrs-full:Revenue
Cost of revenue12 months2021-01-01 to 2021-12-31$415.3mifrs-full:CostOfSales
Gross profit12 months2021-01-01 to 2021-12-31$406.3mifrs-full:GrossProfit
Operating income12 months2021-01-01 to 2021-12-31−$217.4mifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2021-01-01 to 2021-12-31$40.1mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2021-01-01 to 2021-12-31−$319.6mifrs-full:ProfitLossAttributableToOwnersOfParent
Operating cash flow12 months2021-01-01 to 2021-12-31$14.5mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2021-01-01 to 2021-12-31$93.9mifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2021-12-31$223.5mifrs-full:CashAndCashEquivalents
Current assetsAt period end2021-12-31$421.8mifrs-full:CurrentAssets
Total assetsAt period end2021-12-31$1.78bnifrs-full:Assets
Current liabilitiesAt period end2021-12-31$288.4mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2021-12-31$982.7mifrs-full:Liabilities
Shareholders' equityAt period end2021-12-31$755.6mifrs-full:EquityAttributableToOwnersOfParent

Source: SEC EDGAR, the filing index for accession 0001193125-22-096315. Last ingested by Listed: Nov 6, 2026, 12:03 ET. Listed shows no prices and gives no investment advice.